Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

INVO INVO BioScience Inc

0,833

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Micro Cap Massively Bid Up Before Opening Bell

A Florida-based medical device company is finding tremendous success so far during Wednesday’s premarket after the company reported a year-over-year increase in Q4 revenue...

To read the full story on AllPennyStocks.com, click here.

INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more INVO BioScience Charts.

INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more INVO BioScience Charts.

News INVO BioScience Inc

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
Donnerstag 24 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form RW - Registration Withdrawal Request
Dienstag 22 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
Montag 21 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 15 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Montag 14 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 1 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 20 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 18 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 14 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 14 August 2024 (5 Monate vor) • Edgar (US Regulatory)

INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
Mittwoch 14 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Dienstag 21 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Weitere INVO BioScience Inc News-Artikel

Health Care Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen